Application of PD-L1, PD-L2, CD30, CD23 and BCL-6 in Diagnosis and Prognostic Evaluation of Primary Mediastinal Large B-cell Lymphoma

Application of PD-L1, PD-L2, CD30, CD23 and BCL-6 in Diagnosis and Prognostic Evaluation of Primary Mediastinal Large B-cell Lymphoma

Objective To explore the application value of treatment-related markers PD-L1, PD-L2, CD30, CD23, BCL-2, BCL-6, MUM1 and GATA3 in the diagnosis and prognostic evaluation of primary mediastinal B-cell lymphoma(PMBL). Methods A retrospective study was conducted on 34 patients diagnosed with PMBL, and...

Full description

Bibliographic Details
Main Authors: YUAN Ting, CAO Zheng, LIU Xiuyun, ZHENG Bo, FENG Xiaoli
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2021-10-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
lymphoma
mediastinum
immunohistochemistry
pd-l1
pd-l2
cd30
cd23
bcl-6
Online Access:http://html.rhhz.net/ZLFZYJ/html/8578.2020.21.0307.htm

Internet

http://html.rhhz.net/ZLFZYJ/html/8578.2020.21.0307.htm

Similar Items